pyridinoline has been researched along with Thyroid Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garber, J; Greenspan, SL; Lee, SL; Moses, AC; Rosen, HN; Ross, DS | 1 |
| Ban, Y; Ishikawa, N; Ito, K; Momotani, N; Taniyama, M | 1 |
1 trial(s) available for pyridinoline and Thyroid Neoplasms
| Article | Year |
|---|---|
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates.
Topics: Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Biomarkers; Bone and Bones; Bone Resorption; Carcinoma, Papillary; Collagen; Collagen Type I; Creatinine; Diphosphonates; Double-Blind Method; Fasting; Humans; Osteocalcin; Osteolysis; Pamidronate; Peptides; Thyroid Neoplasms; Thyroxine | 1998 |
1 other study(ies) available for pyridinoline and Thyroid Neoplasms
| Article | Year |
|---|---|
Toxic multinodular goitre in a patient with generalized resistance to thyroid hormone who harbours the R429Q mutation in the thyroid hormone receptor beta gene.
Topics: Amino Acids; Biomarkers; Carcinoma, Papillary, Follicular; Female; Goiter, Nodular; Humans; Middle Aged; Mutation; Receptors, Thyroid Hormone; Sex Hormone-Binding Globulin; Tetrahydrocortisol; Tetrahydrocortisone; Thyroid Neoplasms; Thyroidectomy; Thyroxine; Triiodothyronine | 2001 |